生物活性 | |||
---|---|---|---|
描述 | PSI-6130 demonstrates effective and specific inhibitory activity against HCV RNA replication mediated by the NS5B polymerase. PSI-6130 inhibits subgenomic RNA replication of both HCV GT-1b (Con1 strain) and GT-1a (H77 strain), with average EC50 values of 0.51 μM and 0.30 μM, respectively. In the presence of 40% human serum, PSI-6130 maintains its inhibitory effect with an EC50 of 0.51 μM[1]. PSI-6130 inhibits HCV replication with an average IC50 of 0.6 μM, while PSI-6130-TP inhibits the HCV replicase with an average IC50 of 0.34 μM. PSI-6130-TP also inhibits the recombinant HCV Con1 NS5B on a heteropolymeric RNA template derived from the 3' end of the negative strand of the HCV genome, with an IC50 of 0.13 μM and a Ki of 0.023 μM[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.86mL 0.77mL 0.39mL |
19.29mL 3.86mL 1.93mL |
38.58mL 7.72mL 3.86mL |
参考文献 |
---|